Skip to main content

The Parkinson's Progression Markers Initiative is our landmark study launched in 2010 to deepen knowledge of Parkinson's and to better understand its onset and progression to speed the development of new treatments. Learn the latest news from the study here.

  • people sitting classroom style

    PPMI Dispatch: Study Leaders Meet to Chart the Future of Parkinson’s Research

    More than 300 study leaders gathered in New York City for the annual PPMI meeting. They discussed scientific findings from study data and next steps for future research, with a focus on the…

  • Mike Kinnett headshot

    My Research Journey: Why I Raised My Hand to Participate Shortly After Diagnosis

    Sometimes, a long-awaited diagnosis can lead to a certain sense of relief. For Florida resident Mike Kinnett, age 66, the confirmation of a Parkinson’s diagnosis answered several lingering questions,…

  • Vials for research

    Breaking News: Parkinson's Disease Biomarker Found

    New biomarker can reveal key pathology of Parkinson's disease and is a significant milestone in the search for a cure for Parkinson's disease.

  • Default content image

    Major Research Breakthrough: A New Biomarker for Parkinson's

    In this special Third Thursdays Webinar, we discuss the most significant breakthrough to date in the search for a Parkinson’s biomarker: a highly accurate biological test for Parkinson’s disease. The…

  • Hyam and Tom Kramer

    My Research Journey: “Hope begets more hope”

    Hyam Kramer, 62, explains why he joined the premier Parkinson’s research study shortly after receiving a Parkinson’s diagnosis.

  • Two researchers in lab looking at samples

    PPMI Dispatch: Predicting Cognitive Changes and Lipid Levels with a LRRK2 Mutation

    Read the latest scientific findings out of MJFF’s landmark study, the Parkinson’s Progression Markers Initiative, including new insights related to cognitive changes, new LRRK2 findings and…

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.